Role of microRNAs in Non-Alcoholic Steatohepatitis

Author(s): Onpan Cheung, Arun J. Sanyal

Journal Name: Current Pharmaceutical Design

Volume 16 , Issue 17 , 2010

Become EABM
Become Reviewer
Call for Editor


The pathogenesis of non-alcoholic fatty liver disease (NAFLD) is not entirely understood. Recently, the role of microRNA in this liver disease entity and its implication in disease pathogenesis and therapeutic potential has advanced rapidly over the year. While the regulation of miRNA function and its mechanism of actions on translational control of target mRNA expression remain unknown, advances in miRNA research allow identification and biochemical characterization of events that limit protein expression, which is crucial in various forms of human diseases and their subsequent development. It is hoped that further understanding of the role of microRNA in NAFLD will advance potential therapeutics and preventive measures to modify and alter this disease process.

Keywords: microRNA, non-alcoholic steatohepatitis, non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2010
Published on: 01 March, 2012
Page: [1952 - 1957]
Pages: 6
DOI: 10.2174/138161210791208866
Price: $65

Article Metrics

PDF: 17